STAT Plus: Some blood cancer patients see remission with Allogene’s off-the-shelf CAR-T cells, early data show
WELLCOME COLLECTION
Allogene released the first data on tumor responses to its off-the-shelf CAR-T cell therapy for an aggressive form of B-cell lymphoma.
No hay comentarios:
Publicar un comentario